NL-OMON45345已完成不适用
A Phase 1, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses Oral Doses of APX001, to Investigate the Effect of Food on APX001 and to Investigate the Drug-Drug Interaction Potential of APX001 - APX001 Safety, PK, Bioavailability, FE, DDI Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Healthy male or female subjects
- •Age 18 to 55 years, inclusive
- •Body mass index (BMI) between 18.0 and 30.0 kg/m2, inclusive.
排除标准
- •Suffering from cardiovascular, pulmonary, gastrointestinal, metabolic, urogenital, neurological, immunological, psychiatric diseases, or neoplastic disorder with metastatic potential. Participation in a drug study within 60 days prior to (the first) drug administration in the current study. Pregnancy. Suffering from hepatitis B, hepatitis C, HIV/AIDS.
研究者
相似试验
已完成
不适用
A phase 1, randomized, placebo-controlled study to assess the safety and pharmacokinetics of multiple ascending dose regimens of TP-6076.Infecties.Infections.NL-OMON45496Tetraphase Pharmaceuticals, Inc.56
已完成
1 期
A trial of BIT225 in patients with HIV-1 infection, to study the safety, concentration and distribution in the body, and anti-viral activity of the drug.ACTRN12612000696897Biotron Limited24
招募中
1 期
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of PLX-4545 in Healthy VolunteersSolid TumoursCancer - Any cancerACTRN12623001265662Plexium Australia Pty Ltd96
招募中
1 期
A Study to Evaluate the Safety of a Single and Multiple Oral Doses of a Biologic Therapy (MB-001) or placebo in Healthy Human Participantslcerative colitisOral and Gastrointestinal - Inflammatory bowel diseaseUlcerative colitisACTRN12624000524594Mage Biologics48
尚未招募
4 期
Clinical Study to Evaluate the Efficacy and Safety in Healthy Adults for a period of 2 months for the safety endpoints.CTRI/2024/05/066815Herbal Creations